HYPERLIPIDEMIA

This study tested whether a new injectable drug called SHR-1918 could safely lower cholesterol in people whose levels were not well controlled. Forty-four adults received either the drug or a placebo injection over 24 weeks to see how much it reduced their 'bad' LDL cholesterol. …

This study aimed to understand how fat particles called lipoproteins move through the body in healthy people and in people with high cholesterol or other blood fat disorders. Researchers tracked these particles using tiny, safe amounts of radioactive material injected into 759 pa…

This was a small, early-stage study to see how a new drug called HRS-1301 affects the way the body processes a common cholesterol-lowering medicine (rosuvastatin). It involved 16 healthy adults to measure drug levels in the blood and check for safety. The main goal was to gather …

This study aimed to see if measuring how the body handles fats (triglycerides) could help identify which patients with stable heart disease are at higher risk for future heart problems. Researchers followed 514 people with coronary artery disease for 18 months, tracking their tri…

This small study aimed to understand if taking aspirin could prevent the skin flushing that often happens when people take niacin, a cholesterol medication. Nine healthy volunteers took either aspirin or a placebo for five days, then took a dose of niacin. Researchers collected t…

This was the first study in people to test a new drug called HRS-7249, which is being developed to treat high cholesterol. It involved 48 healthy volunteers with high triglycerides to check if a single injection was safe and how the body processed it. The main goal was to find a …

This study aimed to understand how the body processes two common heart medications—one for high cholesterol and one for high blood pressure—when taken as separate pills versus as a single combined pill. It involved 52 healthy male volunteers who received the drugs in different se…

This was an early-stage study to check the safety of a new experimental drug called HRS-1301, which is being developed to treat high cholesterol. It involved 82 healthy volunteers who received either the drug or a placebo. The main goal was to see how well people tolerated the dr…